Form 4 for ELVN Enliven Therapeutics, Inc.
Accepted 2022-12-29 00:00:00 ET · period of report 2022-12-28 · accession 0001567619-22-022103 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-12-29 | 2022-12-28+ | ELVN | Leonard Braden Michael | 10% | S - Sale | $4.04 | -20.0K | 269.8K | -7% | -$80.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-29 | S | D | 19,843 | $4.04 | 250,000 | D | — | — | (F2) The shares were sold in multiple transactions at $4.06. Full information regarding the number of shares sold can be furnished to the SEC staff upon request. |
| 2 | Common | Common Stock | 2022-12-28 | S | D | 157 | $4.04 | 269,843 | D | — | — |